Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

DI STEFANO, Rosa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.359
EU - Europa 1.463
AS - Asia 1.198
SA - Sud America 187
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 6.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.325
SG - Singapore 448
CN - Cina 433
IT - Italia 288
FI - Finlandia 259
UA - Ucraina 243
BR - Brasile 163
RU - Federazione Russa 155
HK - Hong Kong 138
IE - Irlanda 111
DE - Germania 105
GB - Regno Unito 74
SE - Svezia 56
PL - Polonia 55
FR - Francia 45
VN - Vietnam 45
IN - India 26
CA - Canada 16
RO - Romania 16
TR - Turchia 15
KR - Corea 14
AR - Argentina 12
BE - Belgio 12
MX - Messico 12
AT - Austria 10
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 9
NL - Olanda 9
IQ - Iraq 8
JP - Giappone 8
BD - Bangladesh 7
UZ - Uzbekistan 7
ES - Italia 5
IR - Iran 5
ZA - Sudafrica 5
AM - Armenia 4
EG - Egitto 4
JO - Giordania 4
KE - Kenya 4
MA - Marocco 4
MY - Malesia 4
PK - Pakistan 4
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
EC - Ecuador 3
LB - Libano 3
SA - Arabia Saudita 3
TN - Tunisia 3
CH - Svizzera 2
CO - Colombia 2
DZ - Algeria 2
GR - Grecia 2
ID - Indonesia 2
KZ - Kazakistan 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PA - Panama 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.246
Salva come PNG Salva come JPEG
Città #
Fairfield 470
Ashburn 372
Woodbridge 266
Singapore 253
Chandler 227
Houston 188
Wilmington 172
Seattle 162
Ann Arbor 149
Cambridge 149
Jacksonville 132
Hong Kong 130
Dublin 111
Medford 77
Beijing 73
Des Moines 72
Nanjing 67
Moscow 61
Palermo 57
Los Angeles 56
Princeton 46
Zgierz 46
Altamura 41
Boardman 35
San Diego 34
Lawrence 33
Tulsa 32
Shenyang 24
New York 23
Hefei 21
Buffalo 20
Dallas 19
Ho Chi Minh City 18
Jinan 16
Milan 16
Nanchang 16
The Dalles 16
Dearborn 15
Santa Clara 15
Changsha 14
Jiaxing 14
Frankfurt am Main 12
Seongnam 12
Tianjin 12
Zhengzhou 12
Brussels 11
Hebei 11
Izmir 11
Kumar 11
London 11
Hanoi 10
Abidjan 9
Saint Petersburg 8
São Paulo 8
Columbus 7
Ludwigshafen am Rhein 7
Rio de Janeiro 7
Tokyo 7
Bexley 6
Brno 6
Central District 6
Chicago 6
Council Bluffs 6
Curitiba 6
Durham 6
Guangzhou 6
Hangzhou 6
Helsinki 6
Kunming 6
Lake Forest 6
San Mateo 6
San Paolo di Civitate 6
Auburn Hills 5
Fuzhou 5
Haiphong 5
Lanzhou 5
Munich 5
Norwalk 5
Ottawa 5
Phoenix 5
Verona 5
Amman 4
Atlanta 4
Augusta 4
Belo Horizonte 4
Nuremberg 4
Orange 4
Philadelphia 4
Porto Alegre 4
Rome 4
Tashkent 4
Uberlândia 4
Vienna 4
Washington 4
Yerevan 4
Baghdad 3
Bari 3
Brooklyn 3
Campinas 3
Casablanca 3
Totale 4.124
Salva come PNG Salva come JPEG
Nome #
HCV genotypes in Sicily: is there any evidence of a shift? 282
Hepatitis B virus reactivation and alemtuzumab therapy 242
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 231
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin 228
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay 225
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection 214
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial 198
Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The Camporeale Model 184
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial 178
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 171
Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission 171
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. 166
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 166
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 164
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome 155
Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity 154
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction 154
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy 151
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study 150
Modulation of epitope-specific anti-hepatitis C virus E2(anti-HCV/E2)antibodies by anti-viral treatment 146
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 146
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. 136
Sustained response after lamivudine treatment in HBe minus chronic hepatitis B 133
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier 131
Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) 131
VARIABILITY OF THE HBV POL GENE REVERSE-TRANSCRIPTASE DOMAIN IN VIRAL ISOLATES FROM UNTREATED AND LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS 128
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? 126
Infezione occulta da HBV in pazienti con malattie linfoproliferative in trattamento chemioterapico 124
HCV genotypes in western Sicily: any evidence for a shift? 121
Infezione occulta da HBV in pazienti con malattie oncoematologiche 116
Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano 109
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir 107
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 100
Hepatitis C virus clearance and gender 99
Flaviviridae 98
Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale 96
Riattivazione dell'infezione occulta da HBV nel paziente immunocompromesso:studio dell'eterogeneità virale 95
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 92
Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV 87
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 84
ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin 84
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 80
Rhabdoviridae 78
PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? 77
Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients 73
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE 54
Totale 6.435
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.287
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021342 0 0 0 0 0 18 47 31 91 38 50 67
2021/2022497 25 128 0 16 13 17 22 16 68 64 28 100
2022/2023651 71 131 9 58 79 103 51 38 61 2 28 20
2023/2024239 21 35 16 30 29 42 14 14 6 12 0 20
2024/2025817 14 50 41 86 28 36 49 59 68 88 105 193
2025/20261.008 187 78 124 178 245 196 0 0 0 0 0 0
Totale 6.435